| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 10/07/2004 | US20040197782 Nucleic acid sequences mixture for detection of cutaneous t-cell lymphomas (CTCL); antitumor agents |
| 10/07/2004 | US20040197777 Polymorphisms of the OCTN1 and OCTN2 cation transporters associated with inflammatory bowel disorders |
| 10/07/2004 | US20040197776 Identifying microorganismal nucleotide sequences associated with antibiotic resistance protein for use as components to improve identification of vector transformed cells |
| 10/07/2004 | US20040197770 Induction of apoptosis by HIV-1 infected monocytic cells |
| 10/07/2004 | US20040197766 Using transgenic animal models to identify modulator for treatment of obesity, cachexia, diabetes, insulin resistance and eating disorders |
| 10/07/2004 | US20040197390 Mixture of expression vector for antihemophilic factor and lipid; delivering of DNA expression vehicle encoding Factor VIII to a cell |
| 10/07/2004 | US20040197350 Immunizing compositions and methods of use |
| 10/07/2004 | US20040197349 Methods and reagents for vaccination which generate a CD8 T cell immune response |
| 10/07/2004 | US20040197348 Enhanced immune response to attachment (G) protein of respiratory Syncytial virus |
| 10/07/2004 | US20040197347 Induce immunology response; isoation antigen; administering polynucleotide in carrier |
| 10/07/2004 | US20040197346 Materials and methods for intracellular transport and their uses |
| 10/07/2004 | US20040197345 Prostate derived Ets factor |
| 10/07/2004 | US20040197344 Human Leukocyte Antigen (HLA)-based HIV vaccine |
| 10/07/2004 | US20040197338 Sequening peptide fragments which bind to proteins; prevention reproduction of respiratory syncytial virus |
| 10/07/2004 | US20040197325 Antibodies against GPR64 and uses thereof |
| 10/07/2004 | US20040197315 Parkinson's diisease; central nervous system disorders ; Alzheimer's disease; neurodegenerative disorders |
| 10/07/2004 | US20040197314 gene expression of polypeptide in membrane vesicle ; forming antibodies; controlling immunology response |
| 10/07/2004 | US20040197306 Polypeptides; used in diagnosis of gastrointestinal disorders; psoriasis;inflammatory bowel disorders; respiratory system disorders; antiallergens; atherosclerosis |
| 10/07/2004 | US20040197303 For therapy of inflammation and diseases or conditions associated with autoimmune responses |
| 10/07/2004 | DE10313819A1 An MHC-Moleküle bindende Tumor-assoziierte Peptide Binding to MHC molecules tumor-associated peptides |
| 10/07/2004 | DE10313679A1 New protein from Penicillium olsonii that imparts resistance to 2-deoxyglucose, useful in a selection system for transformed organisms |
| 10/07/2004 | CA2731275A1 Tumour-associated peptides binding to mhc-molecules |
| 10/07/2004 | CA2520662A1 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 10/07/2004 | CA2520497A1 Tumour-associated peptides binding to mhc molecules |
| 10/07/2004 | CA2520271A1 Methods for the diagnosis and treatment of epilepsy |
| 10/07/2004 | CA2520257A1 Long acting biologically active conjugates |
| 10/07/2004 | CA2520254A1 Treatment of viral infections |
| 10/07/2004 | CA2520253A1 Interferon-alpha induced gene |
| 10/07/2004 | CA2520138A1 Improved fc fusion proteins |
| 10/07/2004 | CA2520053A1 Infectious bursal disease virus mutants and vaccines |
| 10/07/2004 | CA2520001A1 Cyclic amp response element activator proteins and uses related thereto |
| 10/07/2004 | CA2519922A1 Use of alum and a th1 immune response inducing adjuvant for enhancing immune responses |
| 10/07/2004 | CA2519826A1 Cell death-inducing fusion gene specifically acting on cancer and product thereof |
| 10/07/2004 | CA2519630A1 Gene expression in breast cancer |
| 10/07/2004 | CA2519227A1 Nogo receptor binding protein |
| 10/07/2004 | CA2519165A1 Hiv-peptide-carrier-conjugates |
| 10/07/2004 | CA2519089A1 Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| 10/07/2004 | CA2519057A1 Anti-il-20 antibodies and binding partners and methods of using in inflammation |
| 10/07/2004 | CA2519025A1 Immunogenic hiv-1 multi-clade, multivalent constructs and methods of their use |
| 10/07/2004 | CA2518792A1 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 10/07/2004 | CA2517839A1 Melan-a peptide analogue-virus-like-particle conjugates |
| 10/07/2004 | CA2517836A1 Process for isolating haemocyanin |
| 10/07/2004 | CA2517675A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use |
| 10/07/2004 | CA2517673A1 Improved vaccines for preventing viral infection |
| 10/07/2004 | CA2516414A1 Secreted protein family |
| 10/07/2004 | CA2516163A1 High viscosity xanthan polymer preparations |
| 10/06/2004 | EP1464707A1 Maize alpha-tubulin 3-18 promoter |
| 10/06/2004 | EP1464706A2 HEK5, HEK7, HEK8, HEK11, EPH-like receptor protein tyrosine kinases |
| 10/06/2004 | EP1464705A1 Optimizing cells for endogenous gene activation |
| 10/06/2004 | EP1464704A2 Mouse adhesion molecule occludin |
| 10/06/2004 | EP1464703A2 Canine adhesion molecule occludin |
| 10/06/2004 | EP1464702A1 Method of stabilizing protein |
| 10/06/2004 | EP1464701A1 Fluorescent proteins |
| 10/06/2004 | EP1464654A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/06/2004 | EP1464653A1 Human secreted proteinteins |
| 10/06/2004 | EP1464652A1 GPR54 receptor agonist and antagonist useful for the treatment of gonadotropin related diseases |
| 10/06/2004 | EP1464651A1 Dystrophin-related protein (Drop1), a marker for carcinomas |
| 10/06/2004 | EP1464069A2 Probe for mass spectrometry |
| 10/06/2004 | EP1463949A2 Diagnostics and vaccines for mycobacterium paratuberculosis infections |
| 10/06/2004 | EP1463942A2 Methods for purifying protein |
| 10/06/2004 | EP1463941A1 Novel g-protein coupled receptors |
| 10/06/2004 | EP1463928A2 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer |
| 10/06/2004 | EP1463830A2 Method for classification of anti-psychotic drugs |
| 10/06/2004 | EP1463823A2 Methods of increasing endogenous erythropoietin (epo) |
| 10/06/2004 | EP1463822A2 Cell lines with latent immunodeficiency virus and methods of use thereof |
| 10/06/2004 | EP1463819A1 Hiv-1 virus tat-protein mutants |
| 10/06/2004 | EP1463818A2 Transporters and ion channels |
| 10/06/2004 | EP1463817A2 Histamine receptor h3 polynucleotides |
| 10/06/2004 | EP1463814A2 Polynucleotide encoding a novel trp channel family member, ltrpc3, and splice variants thereof |
| 10/06/2004 | EP1463812A2 Degp protease: cleavage site identification and proteolysis of a natural target in e. coli |
| 10/06/2004 | EP1463811A2 Chitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same |
| 10/06/2004 | EP1463805A2 Adeno-associated virus (aav) serotype 9 sequences, vectors containing same, and uses therefor |
| 10/06/2004 | EP1463760A2 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 10/06/2004 | EP1463759A1 Ligand for g-protein coupled receptor gpr43 and uses thereof |
| 10/06/2004 | EP1463758A2 Mammal prolactin variants |
| 10/06/2004 | EP1463757A2 Antisense compounds directed against human csf-1 |
| 10/06/2004 | EP1463756A2 Secreted proteins |
| 10/06/2004 | EP1463755A2 Recombinant polypeptides |
| 10/06/2004 | EP1463754A2 Cystine-knot fold protein |
| 10/06/2004 | EP1463753A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 10/06/2004 | EP1463752A2 Albumin fusion proteins |
| 10/06/2004 | EP1463751A2 Albumin fusion proteins |
| 10/06/2004 | EP1463747A2 Novel antibodies that bind to antigenic polypeptides,nucleic acids encodings the antigens, and methodes of use |
| 10/06/2004 | EP1463542A2 Method for specifically immobilizing mediator molecules on substrate surfaces |
| 10/06/2004 | EP1463532A2 Dose response-based methods for identifying receptors having alterations in signaling |
| 10/06/2004 | EP1463531A1 Methods for inhibiting ocular processes |
| 10/06/2004 | EP1463530A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles |
| 10/06/2004 | EP1463526A2 Early detection of mycobacterial disease using peptides |
| 10/06/2004 | EP1463525A2 Compositions and methods for the diagnosis and treatment of tumor |
| 10/06/2004 | EP1463523A2 Gpcr-like retinoic acid-induced gene 1 protein and nucleic acid |
| 10/06/2004 | EP1463521A2 Gp41 inhibitor |
| 10/06/2004 | EP1463520A2 Immunisation against chlamydia trachomatis |
| 10/06/2004 | EP1463517A2 Analyse permettant de detecter des facteurs qui modulent l'expression d'ingap |
| 10/06/2004 | EP1463516A2 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 10/06/2004 | EP1349868B1 Process to concentrate insoluble proteins by vibrating membrane filtration |
| 10/06/2004 | EP1242107A4 Method for pr-39 peptide mediated selective inhibition of ikappabalpha degradation |
| 10/06/2004 | EP1185624B1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells |
| 10/06/2004 | EP1101112B1 Leptin-mediated gene-induction |
| 10/06/2004 | EP1071955B1 Improved immunodiagnostic assays using reducing agents |
| 10/06/2004 | EP1056864B1 Constitutive maize promoters |